Cadth 2015 b1 slides allan grill-pcodr-cadth_symposium2015presentationfinal
Corporate presentation (april 2015)
Журнал ЗЛОКАЧЕСТВЕННЫЕ ОПУХОЛИ MALIGNANT TUMOURS № 2-2015 (13) Русскоязычное издание
CANCER COLON AND RECTUM (WARDAH).ppt
Have the OPTIMOX-2, CAIRO-3, COIN, DREAM and other recent trials settled the question of maintenance versus observation in advanced CRC? Yes Deborah Schrag,
Bevacizumab continuation versus no continuation after first-line chemo-bevacizumab therapy in patients with metastatic colorectal cancer: a randomized.
Oral Colorectal Presentations: Discussion Abstracts #4009 - #4011 Cathy Eng, M.D. The University of Texas M.D. Anderson Cancer Center May 31, 2008.
Chemotherapy for Metastatic Colon Cancer Scott Berry Sunnybrook Health Sciences Centre.
1 STN 125085/91 Bevacizumab (Avastin®) plus Paclitaxel for 1 st line Metastatic Breast Cancer ODAC Meeting December 5 th, 2007 Clinical Review - Lee Pai-Scherf,
Jeffrey Meyerhardt, MD, MPH Dana-Farber Cancer Institute Boston, MA
Predicting Safety and Efficacy of Treatment for Colon Cancer Clinical Science Symposium Towards Personalized Medicine: Trials and Technologies That Will.
Introduction
